recent articles
Next-gen sequencing leader joins microprocessing giant to apply genomics and AI technologies toward drug discovery, clinical research, and human health SAN FRANCISCO—Nvidia will partner with Illumina to apply genomics and AI technologies...
Grail’s Billion Dollar Bet for the Perfect Cancer Test
- Advocacy
- Anatomic Pathology
- Business
- Clinical Laboratories
- Clinical Pathology
- Conferences
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- General Healthcare News
- Genetics
- Histology
- Laboratory Informatics
- Laboratory Management & Operations
- Liquid Biopsy
- Medical Research
- Molecular Pathology
- Pathology News
- Science
- Tissue banking
Thought this was worth sharing from MIT Technology Review. After attending ASCO last week what I thought might happen a year or two again actually has. Pathologists no longer have to worry about stepping out from behind the paraffin curtain...
If immunotherapy has the cancer community riveted on the treatment side, liquid biopsies are equally exciting on the diagnostics end. And IBM is bringing its research heft to bear on the world of liquid biopsy with an intent to build a...
Date: Wednesday, February 24 Time: 9:00 AM (PT) Speaker: Claire Ray Associate Product Manager Oncology, Illumina Abstract: Next-generation sequencing (NGS) can help you avoid costly and time-consuming iterative testing while...